arrow
G

Giuseppe Ercolano

university of naples federico ii
H指数:22
被引数:1,902

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction notice to “FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells” [Journal of Controlled Release 382 (2025) 113732]

撤稿通知:“FS536,一种新型一氧化氮释放的阿霉素杂化物,逆转肺癌细胞的多药耐药性”[控制释放杂志 382 (2025) 113732]

2026-05-080
PRE
Addendum: Neural anticipation of virtual infection triggers an immune response

附录:神经对虚拟感染的预期会触发免疫反应

2026-04-240
OAAI
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer

肥大细胞来源的神经营养因子驱动膀胱癌中ILC2的促肿瘤功能

2026-02-210
OAAI
Neural anticipation of virtual infection triggers an immune response

神经对虚拟感染的预期能够触发免疫反应

2025-07-280
OA
Circulating innate lymphoid cells are dysregulated in patients with prostate cancer

前列腺癌患者循环中的固有淋巴细胞失调。

2025-04-180
OA
Pharmacological Inhibition of N-Acylethanolamine Acid Amidase (NAAA) Mitigates Intestinal Fibrosis Through Modulation of Macrophage Activity
2024-08-300
PRE
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer
2024-04-054
OAAI